Links between inflammation and thrombogenicity in atherosclerosis

Area of Science:

• Cardiovascular Science
• Hematology
• Inflammation Research

Background:

• Atherothrombosis, a major cause of cardiovascular events, is driven by plaque disruption and subsequent thrombus formation.
• Vulnerable atherosclerotic lesions contain lipid cores, macrophages, and tissue factor (TF), key initiators of coagulation.
• Cardiovascular risk factors like diabetes, smoking, and dyslipidemia accelerate atherothrombotic processes.

Purpose of the Study:

• To review the critical role of tissue factor (TF) in atherothrombosis.
• To explore the contribution of plaque cell apoptosis and blood thrombogenicity to inflammation and thrombosis.
• To highlight the function of activated platelets in releasing pro-inflammatory cytokines and promoting thrombotic events.

Main Methods:

• Literature review focusing on atherothrombosis mechanisms.
• Analysis of the interplay between inflammation and coagulation.
• Examination of the role of tissue factor (TF) and platelet activation.

Main Results:

• Plaque disruption exposes TF, initiating the coagulation cascade and acute thrombus formation.
• Inflammatory mediators and prothrombotic factors, including TF, apoptosis, and thrombogenicity, are central to atherothrombosis.
• Activated platelets contribute significantly to the inflammatory and thrombotic milieu.

Conclusions:

• Understanding the interaction between inflammation and coagulation is crucial for managing atherothrombotic disease.
• TF, plaque apoptosis, and platelet activation are key targets for therapeutic intervention.
• Addressing cardiovascular risk factors is essential to mitigate the accelerated progression of atherothrombosis.